Pharmacodynamic trial of nimotuzumab in unresectable squamous cell carcinoma of the head and neck: A SENDO Foundation study

Article

Abstract: Purpose: To assess the pharmacodynamic effects of nimotuzumab, an anti-epidermal growth factor recep

Palabras claves:

Autores:

Albanell J., Bellosillo B., Campas C., Cedeño M., Corominas J.M., Corradino I., Cruz T., Gascon P., Gracias E., Iznaga N., Marsoni S., Osorio M., Rojo F., Rovira A., Serrano S., Sessa C., Tania Crombet, Villena N.

Fuentes:

scopus